The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact on survival of primary tumor resection in patients with colorectal cancer and unresectable metastasis: Pooled analysis of individual patients’ data from four randomized trials.
Matthieu Faron
No relevant relationships to disclose
Abderrahmane Bourredjem
No relevant relationships to disclose
Jean-Pierre Pignon
No relevant relationships to disclose
Olivier Bouche
Consultant or Advisory Role - Merck; Roche
Honoraria - Amgen
Jean-Yves Douillard
Consultant or Advisory Role - Roche
Honoraria - Roche
Antoine Adenis
Consultant or Advisory Role - Novartis; Sanofi
Honoraria - Amgen; Bayer; Pfizer; Sanofi
Research Funding - Novartis
Dominique Elias
No relevant relationships to disclose
Michel Ducreux
Consultant or Advisory Role - Merck Serono; Roche
Honoraria - Merck Serono; Roche
Research Funding - Chugai Pharma; Merck Serono; Pfizer